Sau H. Lee

Kuala Selangor, Malaysia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

CRISPR/Cas9 in cancer therapy: clinical translation, mechanistic strategies, and therapeutic directions.

CRISPR/Cas9 in cancer therapy: clinical translation, mechanistic strategies, and therapeutic directions.

Journal: Frontiers in oncology

Published: May 22, 2026

Therapeutic Peptides as Targeting Vectors and Smart Therapeutics: Emerging Trends and Future Perspectives.

Therapeutic Peptides as Targeting Vectors and Smart Therapeutics: Emerging Trends and Future Perspectives.

Journal: Current protein & peptide science

Published: January 04, 2026

Epigenetic reprogramming as the nexus of cancer stemness and therapy resistance: implications for biomarker discovery.

Epigenetic reprogramming as the nexus of cancer stemness and therapy resistance: implications for biomarker discovery.

Journal: Discover oncology

Published: August 05, 2025

Dox-HCl and miR-145 co-delivery through CD44-targeted PEGylated liposomes inhibit Breast Cancer in vitro via augmenting PI3K/AKT pathway.

Dox-HCl and miR-145 co-delivery through CD44-targeted PEGylated liposomes inhibit Breast Cancer in vitro via augmenting PI3K/AKT pathway.

Journal: Nanomedicine (London, England)

Published: July 30, 2025

Truncated pardaxin derivative D18.13 induces selective breast cancer apoptosis via predicted targeting of MAPK8.

Truncated pardaxin derivative D18.13 induces selective breast cancer apoptosis via predicted targeting of MAPK8.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: July 25, 2025

The genetic landscape of CYP24A1 polymorphisms in cancer risk: evidence from a systematic review.

The genetic landscape of CYP24A1 polymorphisms in cancer risk: evidence from a systematic review.

Journal: Discover oncology

Published: December 27, 2024

Inhibition of EREG/ErbB/ERK by Astragaloside IV reversed taxol-resistance of non-small cell lung cancer through attenuation of stemness via TGFβ and Hedgehog signal pathway.

Inhibition of EREG/ErbB/ERK by Astragaloside IV reversed taxol-resistance of non-small cell lung cancer through attenuation of stemness via TGFβ and Hedgehog signal pathway.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: September 25, 2024

Precision-engineered PEGylated liposome for dual payload delivery: enhancing efficacy of Doxorubicin hydrochloride and miR-145 mimics in breast cancer cells.

Precision-engineered PEGylated liposome for dual payload delivery: enhancing efficacy of Doxorubicin hydrochloride and miR-145 mimics in breast cancer cells.

Journal: Journal of liposome research

Published: August 05, 2024

Comprehensive review of opportunities and challenges of ethnomedicinal plants for managing type 2 diabetes.

Comprehensive review of opportunities and challenges of ethnomedicinal plants for managing type 2 diabetes.

Journal: Heliyon

Published: April 08, 2024

Novel detoxifier of spironolactone against triptolide-induced hepatotoxicity through inhibition of RPB1 degradation.

Novel detoxifier of spironolactone against triptolide-induced hepatotoxicity through inhibition of RPB1 degradation.

Journal: Journal of ethnopharmacology

Published: March 18, 2024

Short Fragmented Peptides from Pardachirus Marmoratus Exhibit Stronger Anticancer Activities in In Silico Residue Replacement and Analyses.

Short Fragmented Peptides from Pardachirus Marmoratus Exhibit Stronger Anticancer Activities in In Silico Residue Replacement and Analyses.

Journal: Current drug discovery technologies

Published: November 02, 2023

Association of microRNA-21 expression with breast cancer subtypes and its potential as an early biomarker.

Association of microRNA-21 expression with breast cancer subtypes and its potential as an early biomarker.

Journal: Pathology, research and practice

Published: October 12, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026